Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Journal of Pharmacology

• Publication date

  1995-02-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0014-2999(94)00712-GPMID 7768282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• On the Purkinje cell activity increase induced by suppression of inferior olive activity

  2004cited by this paper
• TRH analogue, TA-0910 (3-methyl-(s)-5,6-dihydroorotyl-L-histidyl-L-prolinamide) enhances neurite outgrowth in rat embryo ventral spinal cord in vitro.

  1992cited by this paper
• Rolling mouse Nagoya as a mutant animal model of basal ganglia dysfunction: determination of absolute rates of local cerebral glucose utilization.

  1992cited by this paper
• Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (III): Inhibition of pentobarbital anesthesia.

  1991cited by this paper
• Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA-0910.

  1991cited by this paper
• Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): Effects on the central nervous system by oral administration.

  1990cited by this paper
• Effect of thyrotropin-releasing hormone on the time course of neurologic recovery after spinal cord injury in the rat.

  1990cited by this paper
• Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety.

  1990cited by this paper
• Thyrotropin-Releasing Hormone: Biomedical Significance

  1989cited by this paper
• A Summary of the Current Position of TRH in ALS Therapy a

  1989cited by this paper
• Spinal cord immunoreactive TRH is altered after local traumatic injury.

  1987cited by this paper
• Temporal sequence of motor disturbances and increased cerebellar glutamic acid decarboxylase activity following 3-acetylpyridine lesions in adult rats.

  1987cited by this paper
• Changes in TRH immunoreactivity in spinal cord after experimental spinal injury.

  1986cited by this paper
• Pharmacology of thyrotropin-releasing hormone.

  1986cited by this paper
• [Histydyl-proline diketopiperazine (HPD), a metabolite of thyrotropin-releasing hormone (TRH), improves the ataxic gait in 3-acetylpyridine (3-AP) treated rats].

  1986cited by this paper
• Effects of thyrotropin-releasing hormone tartrate (TRH-T) and its main metabolite histidyl-proline diketopiperazine on the walking ataxia in Rolling mouse Nagoya

  1985cited by this paper
• Thyrotropin‐releasing hormone in experimental spinal injury

  1984cited by this paper
• Absorption of thyrotropin-releasing hormone after oral administration of TRH tartrate monohydrate in the rat, dog and human.

  1984cited by this paper
• Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats.

  1982cited by this paper
• Regulatory peptides as a source of new drugs--the clinical prospects for analogues of TRH which are resistant to metabolic degradation.

  1982cited by this paper
• TRH and spinocerebellar degeneration.

  1982cited by this paper
• Central noradrenaline metabolism in cerebellar ataxic mice

  1982cited by this paper
• Neurotransmitter abnormality in Rolling mouse Nagoya, an ataxic mutant mouse.

  1981cited by this paper
• Thyrotropin-Releasing Hormone Improves Neurologic Recovery after Spinal Trauma in Cats

  1981cited by this paper
• [Noradrenaline metabolism in the brain of rolling mouse Nagoya and the influence of thyrotropin releasing hormone (author's transl)].

  1980cited by this paper
• Thyrotropin-releasing hormone (TRH) in rat spinal cord.

  1977cited by this paper
• Inferior olive: its role in motor learing

  1975cited by this paper
• Depressant action of TRH, LH-RH and somatostatin on activity of central neurones

  1975cited by this paper
• Effects of 3-acetylpyridine on the central nervous system of the rat, as demonstrated by silver methods.

  1974cited by this paper
• Distribution and concentration of TRH in the rat brain.

  1974cited by this paper
• Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans.

  1973cited by this paper

• Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.

  2020cites this paper
• Taltirelin alleviates fatigue‐like behavior in mouse models of cancer‐related fatigue

  2017cites this paper
• Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.

  2015cites this paper
• Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate

  2011cites this paper
• Secondary amenorrhea in a woman with spinocerebellar degeneration treated with thyrotropin-releasing hormone: a case report and in vitro analysis

  2011cites this paper
• Oral Administration of the Thyrotropin-Releasing Hormone (TRH) Analogue, Taltireline Hydrate, in Spinal Muscular Atrophy

  2009cites this paper
• Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.

  2005cites this paper
• GPCR agonists and antagonists in the clinic.

  2005cites this paper
• Taltirelin improves motor ataxia independently of monoamine levels in rolling mouse nagoya, a model of spinocerebellar atrophy.

  2005cites this paper
• Thyrotropin-releasing hormone receptors -- similarities and differences.

  2003cites this paper
• 3-acetylpyridine reduces tongue protrusion force but does not abolish lick rhythm in the rat.

  2001cites this paper
• Expression of thyrotropin‐releasing hormone receptor 2 (TRH‐R2) in the central nervous system of rats

  2000cites this paper
• Metabolic abnormalities caused by 3-acetylpyridine in the cerebral motor regions of rats: partial recovery by thyrotropin-releasing hormone.

  2000cites this paper
• Taltirelin (Tanabe Seiyaku).

  1999cites this paper
• An update on the CNS actions of TRH and its analogs.

  1998cites this paper
• Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.

  1998cites this paper
• TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats.

  1998cites this paper
• Taltirelin Hydrate (TA‐0910): An Orally Active Thyrotropin‐Releasing Hormone Mimetic Agent with Multiple Actions

  1998cites this paper
• Distribution of thyrotropin-releasing hormone (TRH) receptors in the brain of the ataxic mutant mouse, rolling mouse Nagoya.

  1997cites this paper
• Chronic anti-ataxic actions of the novel thyrotropin-releasing hormone (TRH) analog, TA-0910, during and after repeated administration in Rolling mouse Nagoya: behavioral and pharmacokinetic studies.

  1997cites this paper
• A new method for evaluation of motor deficits in 3-acetylpyridine-treated rats.

  1997cites this paper
• TRH系ペプチド(タルチレリン)の合成とその薬理活性

  1997cites this paper
• Effect of TA-0910, a novel thyrotropin-releasing hormone analog, on in vivo acetylcholine release and turnover in rat brain.

  1996cites this paper
• Anti‐ataxic effects of TRH and its analogue, TA‐0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area

  1995cites this paper